Antares Pharma, Inc.
ATRS
ATRS was delisted on the 23rd of May, 2022.
81 hedge funds and large institutions have $127M invested in Antares Pharma, Inc. in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 13 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 20
18% more capital invested
Capital invested by funds: $107M → $127M (+$19.2M)
7% less funds holding
Funds holding: 87 → 81 (-6)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
79% less call options, than puts
Call options by funds: $63K | Put options by funds: $294K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$10.1M |
| 2 |
AC
Armistice Capital
New York
|
+$3.04M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$753K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$228K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WHI
William Harris Investors
Chicago,
Illinois
|
-$1.38M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$598K |
| 3 |
MC
Menta Capital
San Francisco,
California
|
-$398K |
| 4 |
Renaissance Technologies
New York
|
-$221K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$142K |
ATRS Hedge Fund Activity: Q1 2015 in Review
81 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q1 2015, worth a combined $127M — up 18% from $107M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ATRS and 7 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 28 added.
The largest buyer was Deerfield Management, adding an estimated $10.1M. The largest seller was William Harris Investors, cutting an estimated $1.38M.
- 81 institutional investors held Antares Pharma, Inc. (ATRS) as of Q1 2015, down from 87 in Q4 2014.
- Funds reported $127M of Antares Pharma, Inc. stock for Q1 2015, up 18% quarter-over-quarter.
- 7 funds opened new Antares Pharma, Inc. positions in Q1 2015 and 13 closed out, a net change of -6 holders.
- The largest Antares Pharma, Inc. buyer in Q1 2015 was Deerfield Management, an estimated $10.1M added.
- The largest Antares Pharma, Inc. seller in Q1 2015 was William Harris Investors, an estimated $1.38M sold.
Based on aggregated 13F filings for Q1 2015.